We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
FedEx
FDX
$75.4B
| $4.27M | 0.03% |
16,437
+4,642
| +39% | +$1.29M |
|
352
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $4.23M | 0.03% |
21,737
+2,764
| +15% | +$505K |
|
353
Bilibili
BILI
$7.84B
| $4.21M | 0.03% |
49,140
+31,051
| +172% | +$1.82M |
|
354
State Street SPDR S&P China ETF
GXC
$482M
| $4.18M | 0.03% |
32,109
+2,426
| +8% | +$308K |
|
355
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $4.14M | 0.03% |
42,720
+7,011
| +20% | +$632K |
|
356
Air Products & Chemicals
APD
$67.6B
| $4.12M | 0.03% |
15,068
+2,644
| +21% | +$745K |
|
357
L3Harris
LHX
$53.4B
| $4.11M | 0.03% |
21,728
+9,462
| +77% | +$1.73M |
|
358
Iridium Communications
IRDM
$5.29B
| $4.03M | 0.03% |
102,545
+35,779
| +54% | +$1.12M |
|
359
Fortinet
FTNT
$117B
| $4.02M | 0.03% |
135,365
+62,330
| +85% | +$1.58M |
|
360
VeriSign
VRSN
$26.6B
| $3.99M | 0.03% |
18,455
+9,063
| +96% | +$1.85M |
|
361
iShares Russell 2000 Value ETF
IWN
$14.6B
| $3.94M | 0.03% |
29,909
+20,064
| +204% | +$2.37M |
|
362
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $3.93M | 0.03% |
48,334
+4,370
| +10% | +$318K |
|
363
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $3.91M | 0.03% |
75,628
-332
| -0.4% | -$16.1K |
|
364
Humana
HUM
$46.2B
| $3.88M | 0.03% |
9,455
+2,551
| +37% | +$1.06M |
|
365
Travelers Companies
TRV
$80.2B
| $3.88M | 0.03% |
27,613
+23,528
| +576% | +$3.02M |
|
366
Lam Research
LRCX
$390B
| $3.86M | 0.03% |
81,730
+34,730
| +74% | +$1.46M |
|
367
Paychex
PAYX
$42.7B
| $3.85M | 0.03% |
41,319
+5,849
| +16% | +$519K |
|
368
Canadian National Railway
CNI
$76.6B
| $3.82M | 0.03% |
34,796
-1,300
| -4% | -$140K |
|
|
PARA
369
DELISTED
Paramount Global Class B
PARA
| $3.82M | 0.03% |
102,534
-18,258
| -15% | -$586K |
|
370
Advanced Micro Devices
AMD
$789B
| $3.82M | 0.03% |
41,635
+11,560
| +38% | +$998K |
|
371
Roku
ROKU
$22.7B
| $3.8M | 0.03% |
11,453
+1,821
| +19% | +$478K |
|
372
NetEase
NTES
$84.7B
| $3.79M | 0.03% |
39,621
+2,811
| +8% | +$252K |
|
|
XLNX
373
DELISTED
Xilinx Inc
XLNX
| $3.77M | 0.03% |
26,611
+15,896
| +148% | +$2.07M |
|
374
First Trust Enhanced Short Maturity ETF
FTSM
$6.5B
| $3.76M | 0.03% |
62,648
-2,234
| -3% | -$134K |
|
375
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.38B
| $3.75M | 0.03% |
72,839
-14,777
| -17% | -$762K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.